Northeast Investment Management Abb Vie Inc. Transaction History

Northeast Investment Management

$2.18 Billion
Q3 2024

A detailed history of Northeast Investment Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Northeast Investment Management holds 11,964 shares of ABBV stock, worth $2.15 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

11,964

Previous 12,066 0.85%

Holding current value

$2.15 Million

Previous $2.07 Million 14.16%

% of portfolio

0.11%

Previous 0.1%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$163.84 - $199.33 $16,711 - $20,331	-102 Reduced 0.85%	11,964 $2.36 Million
Q2 2024 Jul 26, 2024	BUY	$154.79 - $180.76 $57,117 - $66,700	369 Added 3.15%	12,066 $2.07 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $159,065 - $179,145	-1,156 Reduced 8.99%	11,697 $1.81 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $164,716 - $190,683	-1,233 Reduced 8.75%	12,853 $1.92 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $6,227 - $7,750	-47 Reduced 0.33%	14,086 $1.9 Million
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $68,834 - $79,273	-476 Reduced 3.26%	14,133 $2.25 Million
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $273,577 - $328,090	-1,978 Reduced 11.93%	14,609 $2.36 Million
Q3 2022 Oct 28, 2022	SELL	$134.21 - $153.93 $14,494 - $16,624	-108 Reduced 0.65%	16,587 $2.23 Million
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $45,689 - $58,086	332 Added 2.03%	16,695 $2.56 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $34,314 - $42,575	260 Added 1.61%	16,363 $2.65 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $151,476 - $191,661	1,410 Added 9.6%	16,103 $2.18 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $89,269 - $101,334	839 Added 6.06%	14,693 $1.59 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $7,785 - $8,673	74 Added 0.54%	13,854 $1.56 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $88,591 - $97,528	866 Added 6.71%	13,780 $1.49 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $38,184 - $57,891	-592 Reduced 4.38%	12,914 $984,000
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $2,452 - $3,068	34 Added 0.25%	13,506 $1.2 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $51,076 - $61,408	-811 Reduced 5.68%	13,472 $1.02 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $321,667 - $411,166	4,896 Added 52.16%	14,283 $1.04 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $43,506 - $51,205	-564 Reduced 5.67%	9,387 $756,000
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $13,935 - $17,185	179 Added 1.83%	9,951 $917,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $24,805 - $27,576	-279 Reduced 2.78%	9,772 $924,000
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $3,411 - $4,036	38 Added 0.38%	10,051 $931,000
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $1,840 - $2,464	-20 Reduced 0.2%	10,013 $948,000
Q4 2017 Jan 29, 2018	SELL	$89.56 - $98.21 $1,880 - $2,062	-21 Reduced 0.21%	10,033 $970,000
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $702,271 - $897,017	10,054	10,054 $893,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Investment Management with notifications on news.

Account

Northeast Investment Management Abb Vie Inc. Transaction History